SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-561311
Filing Date
2016-04-28
Accepted
2016-04-28 09:00:39
Documents
15
Period of Report
2016-06-07
Effectiveness Date
2016-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A d159107ddef14a.htm DEF 14A 453547
2 GRAPHIC g159107g66r19.jpg GRAPHIC 34521
3 GRAPHIC g159107pcpg01a.jpg GRAPHIC 12905
4 GRAPHIC g159107pcpg01b.jpg GRAPHIC 1593
5 GRAPHIC g159107pcpg01c.jpg GRAPHIC 1564
6 GRAPHIC g159107pcpg01d.jpg GRAPHIC 24542
7 GRAPHIC g159107pcpg01enew1.jpg GRAPHIC 2285
8 GRAPHIC g159107pcpg01f.jpg GRAPHIC 596
9 GRAPHIC g159107pcpg01g.jpg GRAPHIC 796
10 GRAPHIC g159107pcpg01hnew1.jpg GRAPHIC 11034
11 GRAPHIC g159107pcpg01inewv1.jpg GRAPHIC 12479
12 GRAPHIC g159107pcpg02a.jpg GRAPHIC 1101
13 GRAPHIC g159107pcpg02b.jpg GRAPHIC 1224
14 GRAPHIC g159107pcpg02c.jpg GRAPHIC 888
15 GRAPHIC g159107pcpg02d.jpg GRAPHIC 806
  Complete submission text file 0001193125-16-561311.txt   602767
Mailing Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-741-0900
MyoKardia Inc (Filer) CIK: 0001552451 (see all company filings)

IRS No.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37609 | Film No.: 161597361
SIC: 2834 Pharmaceutical Preparations